What is the recommended diagnostic workup for adrenal nodules, including the role of MRI (Magnetic Resonance Imaging)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MRI for Adrenal Nodules: When to Order

MRI (specifically chemical shift MRI) should be ordered as second-line imaging for adrenal nodules that are indeterminate on non-contrast CT (Hounsfield units >10), serving as an alternative to washout CT to characterize the lesion. 1

Initial Imaging Strategy

  • Non-contrast CT is the first-line imaging modality for all adrenal nodules to measure Hounsfield units (HU) and provide initial characterization 2
  • Lesions with HU ≤10 are definitively benign (lipid-rich adenomas) and do not require MRI or any further imaging unless they are ≥4 cm 1, 2
  • Lesions with HU >10 are indeterminate and require second-line imaging 1

When MRI is Indicated

Chemical shift MRI should be ordered when:

  • The adrenal mass shows HU >10 on non-contrast CT, making it indeterminate for adenoma versus other pathology 1, 2
  • You need an alternative to washout CT (either option is acceptable per guidelines) 1
  • The patient has suspected pheochromocytoma, where MRI is preferred over contrast-enhanced CT due to risk of hypertensive crisis from IV contrast 1
  • Radiation safety is a concern, particularly in young adults, children, or pregnant patients where low-dose CT or chemical shift MRI should be preferred 1, 3

How Chemical Shift MRI Works

  • Chemical shift MRI detects microscopic fat by exploiting different proton frequencies in water versus fat 1
  • Homogeneous signal intensity drop on opposed-phase images is diagnostic of lipid-rich adenoma 1
  • Heterogeneous signal intensity drop is more controversial, as minute amounts of microscopic fat can occur in pheochromocytoma, adrenocortical carcinoma, and some metastases 1
  • However, heterogeneous microscopic fat still indicates high likelihood of benignancy, particularly in patients without prior cancer (0% malignancy rate in one multicenter study) 4

Critical Limitations of Alternative Imaging

Washout CT has significant pitfalls that make MRI attractive:

  • Approximately 1/3 of pheochromocytomas may washout in the characteristic range of an adenoma (false negative) 1
  • Approximately 1/3 of adrenal adenomas do not washout in the adenoma range (false positive) 1
  • Malignant masses (adrenocortical carcinoma, hypervascular metastases) can also washout in the adenoma range 1

When MRI is NOT Needed

  • Benign non-functional adenomas <4 cm with HU <10 require no further imaging 1, 2
  • Myelolipomas and masses containing macroscopic fat identified on initial CT require no further imaging 1
  • Lesions that are clearly malignant on CT (large, heterogeneous, irregular margins) should proceed directly to surgical planning rather than additional characterization 1

Common Pitfalls to Avoid

  • Never order MRI before excluding pheochromocytoma hormonally if planning contrast-enhanced studies, as IV contrast can precipitate hypertensive crisis 1
  • Do not skip hormonal evaluation even when ordering MRI for radiologic characterization—all adrenal incidentalomas require functional testing regardless of imaging appearance 1, 2
  • Do not order MRI for routine follow-up of already-characterized benign lesions <4 cm, as this provides no additional benefit 1, 3
  • Be aware that heterogeneous signal loss on chemical shift MRI does not definitively exclude malignancy in patients with prior cancer, particularly hepatocellular carcinoma or renal cell carcinoma which may contain fat 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Adrenal Nodules

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adrenal Nodules Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.